The Bryomixol Cancer Treatment

Pharmatech S.A. de C.V.

Los Angeles, CA phone: (714) 785-4473
Thursday, February 12, 2009

According to a USA Today article, The Journal of Oncology Practice, says the number of Americans who are diagnosed with cancer — both those in treatment and those who have finished therapy — will grow to 18.2 million, up from 11.7 million in 2005. Today, about one in 26 Americans has had cancer. By 2020, roughly one in 19 will have been diagnosed with the disease, says Edward Salsberg, an author of the study from the Association of American Medical Colleges' Center for Workforce Studies.

 

The increase in cancer diagnosis has lead many to seek an alternative in cancer treatment and care. Bryomixol responds to this need by providing a 100% natural cancer treatment program without side effects or toxicity, lead by a team of board certified oncologists and physicians.

 

The Bryomixol program is an integrative immune-boosting program that has been on the market for over 25 years and treated more than 15,000 patients.  Bryomixol can be used alongside more traditional cancer care without disrupting treatment. 

 

Learn More>>

© 2008 altMD, LLC. All rights reserved. Use of this site constitutes acceptance of altMD's terms of service and privacy policy. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.